A review of telavancin in the treatment of complicated skin and skin structure infections (cSSSI)
Authors:
Open Access
- 1 February 2008
- journal article
- review article
- Published by Taylor & Francis in Therapeutics and Clinical Risk Management
- Vol. ume 4 (1) , 235-244
Abstract
Dove Press is a member of the Open Access Initiative, specializing in peer reviewed Medical Journals. View articlesor submit your research for publishingKeywords
This publication has 42 references indexed in Scilit:
- In Vitro Activity of Telavancin against Gram-Positive Clinical Isolates Recently Obtained in EuropeAntimicrobial Agents and Chemotherapy, 2007
- Comparative activity of the new lipoglycopeptide telavancin in the presence and absence of serum against 50 glycopeptide non-susceptible staphylococci and three vancomycin-resistant Staphylococcus aureusJournal of Antimicrobial Chemotherapy, 2006
- Bad Bugs Need Drugs: An Update on the Development Pipeline from the Antimicrobial Availability Task Force of the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2006
- Telavancin versus Standard Therapy for Treatment of Complicated Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: FAST 2 StudyAntimicrobial Agents and Chemotherapy, 2006
- Efficacy of Telavancin (TD-6424), a Rapidly Bactericidal Lipoglycopeptide with Multiple Mechanisms of Action, in a Murine Model of Pneumonia Induced by Methicillin-Resistant Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 2005
- Telavancin Versus Standard Therapy for Treatment of Complicated Skin and Soft-Tissue Infections Due to Gram-Positive BacteriaClinical Infectious Diseases, 2005
- Clostridium clostridioforme: a mixture of three clinically important speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2005
- Glycopeptides in clinical development: pharmacological profile and clinical perspectivesCurrent Opinion in Pharmacology, 2004
- Hospital-acquired infections: diseases with increasingly limited therapies.Proceedings of the National Academy of Sciences, 1994
- Quantitative Action of Penicillin Inhibitor from Penicillin-Resistant Strains of StaphylococciScience, 1945